Please login to the form below

Not currently logged in
PMLiVE Top Pharma List


The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Endo's 2013 CNS (central nervous system) sales performance.

Endo Health Solutions

Shire rumoured to be pursuing Actelion

Shire rumoured to be pursuing Actelion Meanwhile, Mylan is pursuing Perrigo whilst in turn being pursued by Teva, and Endo has an $8bn merger with Par in play.

Pharma deals in May 2015

Pharma deals in May 2015 With a similar headline value to Synageva/Alexion and building on its acquisition plans was the purchase of Par Pharmaceuticals by Endo. ... Clearly the money was burning a hole in the Endo shareholders' pockets and this will consolidate the company's

Perrigo warming to Mylan - at the right price

Perrigo warming to Mylan - at the right price Most recently, Endo has just agreed an $8.1bn deal to acquire Par Pharmaceutical and boost its generics business. .

Endo buys Par for $8bn as M&A mania marches on

Endo buys Par for $8bn as M&A mania marches on Endo is the latest to step up, offering just over $8bn for Par Pharmaceutical in order to boost its generics business. ... Paul Campanelli, Par's CEO, will join Endo to lead its generics business.

Actavis completes $70.5bn Allergan acquisition

Actavis completes $70.5bn Allergan acquisition But Valeant may not be too disappointed as just this week, the firm raised its offer for specialty drugmaker Salix - after its previous bid was trumped by Ireland-based Endo - and

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs


Add my company
Empowering Strategic Performance Ltd

OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...

Latest intelligence

“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...
Pharma M&A
Pharma funding and M&A in 2020
Why pharma M&A has continually bucked the trend...